Question 1

What is combined oxidative phosphorylation deficiency 45?

Accepted Answer

Combined oxidative phosphorylation deficiency 45 is a multisystem condition that disrupts the body’s ability to generate energy effectively. It is caused by changes in the MRPL12 gene, which plays a critical role in mitochondrial protein synthesis. Typically, affected individuals present in early childhood with features affecting multiple organ systems. As precise prevalence estimates are not available, the disorder is understood to be very rare.

Question 2

What are the symptoms of combined oxidative phosphorylation deficiency 45?

Accepted Answer

The clinical presentation of combined oxidative phosphorylation deficiency 45 is strikingly multisystem. Neurologically, affected children exhibit global developmental delay, absent speech, seizures, ataxia, tremor, and abnormal cerebral white matter morphology, all of which highlight central nervous system involvement. In addition, they show axial hypotonia, failure to thrive, and increased circulating lactate concentration, suggesting impaired mitochondrial function. Facial differences, such as epicanthus, round face, high palate, and low-set ears, along with ocular manifestations like horizontal nystagmus, further characterize the condition. Cardiac arrest and a short neck are also consistently reported. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes combined oxidative phosphorylation deficiency 45?

Accepted Answer

This condition is caused by pathogenic variants in the MRPL12 gene, which encodes a mitochondrial ribosomal protein essential for proper energy production within cells. It is inherited in an autosomal recessive pattern, meaning that affected individuals have received two altered copies of the gene, one from each parent. When both parents carry the change, there is a 25% chance in each pregnancy of having an affected child. Genetic counseling is recommended for families to better understand inheritance risks and to discuss options for future family planning. Associated genes include MRPL12.

Question 4

How is combined oxidative phosphorylation deficiency 45 inherited?

Accepted Answer

combined oxidative phosphorylation deficiency 45 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is combined oxidative phosphorylation deficiency 45 diagnosed?

Accepted Answer

Diagnosis is confirmed through molecular genetic testing that identifies pathogenic variants in the MRPL12 gene. Alongside genetic testing, clinicians evaluate the constellation of clinical features such as global developmental delay, seizures, elevated lactate levels, along with distinct facial and ocular findings. As many of these symptoms can overlap with other conditions, genetic confirmation is essential to distinguish combined oxidative phosphorylation deficiency 45 from similar disorders.

Question 6

Are there treatments for combined oxidative phosphorylation deficiency 45?

Accepted Answer

Currently, management focuses on supportive care and symptom relief, with treatment plans tailored to the individual's needs. Because there are no approved or foundational therapies specific to this condition, a multidisciplinary team usually coordinates care to address neurological, cardiac, and nutritional issues, among others. Regular surveillance is an essential part of long-term management and helps to identify complications early. Patients should discuss treatment options with their healthcare team and consider genetic counseling as part of comprehensive care.

Question 7

What are the potential complications of combined oxidative phosphorylation deficiency 45?

Accepted Answer

Individuals with combined oxidative phosphorylation deficiency 45 can face various complications due to the multisystem nature of the condition. These may include neurological issues like seizures and developmental delays, as well as cardiac problems such as cardiac arrest. Regular monitoring and supportive care are crucial to manage these complications and improve quality of life.

Question 8

How does combined oxidative phosphorylation deficiency 45 affect daily life for patients and their families?

Accepted Answer

Living with combined oxidative phosphorylation deficiency 45 can be challenging for both patients and their families. Daily life may involve managing symptoms like seizures and developmental delays, which can require specialized care and therapy. Families often need to coordinate with a multidisciplinary team to address the various needs of their loved one, including neurological, cardiac, and nutritional support.

Question 9

What is the prognosis for individuals with combined oxidative phosphorylation deficiency 45?

Accepted Answer

The prognosis for individuals with combined oxidative phosphorylation deficiency 45 varies widely among patients. While the condition is lifelong, many patients benefit from ongoing supportive treatments that can enhance their quality of life. Factors such as age at diagnosis and access to specialized care can significantly influence the disease's progression and outcomes.

Question 10

Are there any specific specialists recommended for managing combined oxidative phosphorylation deficiency 45?

Accepted Answer

Families dealing with combined oxidative phosphorylation deficiency 45 are encouraged to connect with specialists who are familiar with the condition. A multidisciplinary team, including neurologists, cardiologists, and nutritionists, can provide comprehensive care tailored to the individual's needs. Regular follow-ups with these specialists are essential for monitoring the patient's health and addressing any emerging complications.

Organ System	Phenotype Count	Example Features
Brain and nerves	6	Absent speech, Seizure, Global developmental delay
Lab test results

Research Type	Count	% of Total
Laboratory research	27	64%

Kisho

combined oxidative phosphorylation deficiency 45

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

combined oxidative phosphorylation deficiency 45

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is combined oxidative phosphorylation deficiency 45?

What are the symptoms of combined oxidative phosphorylation deficiency 45?

What causes combined oxidative phosphorylation deficiency 45?

How is combined oxidative phosphorylation deficiency 45 inherited?

How is combined oxidative phosphorylation deficiency 45 diagnosed?

Are there treatments for combined oxidative phosphorylation deficiency 45?

What are the potential complications of combined oxidative phosphorylation deficiency 45?

How does combined oxidative phosphorylation deficiency 45 affect daily life for patients and their families?

What is the prognosis for individuals with combined oxidative phosphorylation deficiency 45?

Are there any specific specialists recommended for managing combined oxidative phosphorylation deficiency 45?

Explore clinical features

Recent Publications